Actuate Therapeutics, Inc. ACTU
0.68
0.06
9.68%
as of 25 Sep
- Market cap
- $15.9M
- P/E
- 0.0×
Follow ACTU
| Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|
Current Ratio |
0.43 | 1.05 | 2.39 |
Net Debt/EBITDA |
0.12 | 0.34 | 0.59 |
Debt/Assets |
0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 |
Asset Turnover |
— | 0.00 | 0.00 |
Operating CF/Net income |
0.87 | 0.80 | 0.86 |
Interest Coverage |
0.00 | 0.00 | 0.00 |
| 0.00% | 54.83% | (553.75%) | |
| 0.00% | (443.16%) | (190.35%) | |
ROIC |
0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
630.44% | (6,730.46%) | (280.07%) |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(15.07) | (2.61) | (0.91) |
Cash per Share |
2.06 | 1.03 | 0.63 |
Shareholders Equity per Share |
(69.43) | 0.01 | 0.38 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 |
Book value per Share |
(69.43) | 0.01 | 0.38 |
Free Cash Flow |
(21.63) | (21.84) | (19.21) |
Working Capital |
(3.92) | 0.41 | 7.94 |
Net Current Asset Value |
(99.63) | (0.01) | 7.53 |
| Other line items | |||
Quick Ratio |
0.43 | 0.98 | 2.31 |
Cash ROIC |
22.37% | (249.75%) | (91.10%) |
Accounts Payable Turnover |
— | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 0.00 |
Revenue per Share |
0.00 | 0.00 | 0.00 |
Operating CF per Share |
(15.07) | (2.61) | (0.91) |
Capex per Share |
0.00 | 0.00 | 0.00 |
Average Payables |
— | 2.67 | 1.72 |
Average Assets |
— | 6.16 | 11.68 |
Average Common Equity |
— | (49.76) | 4.01 |
Net Profit Margin |
0.00% | 0.00% | 0.00% |
Columns are period end dates